A new anti-inflammatory drug that prevents the immune system from causing irrevocable brain and tissue damage could help improve the survival rate of people with severe malaria, according to a new study.
Malaria kills up to one million people worldwide every year, particularly children under five and pregnant women. Symptoms include brain damage and multiple organ failure.
The active agents in the anti-inflammatory drug are cheap to produce and easy to use, making them a good option for medical treatments in developing countries, according to the researchers.
Read more at Walter and Eliza Hall Institute